Hims, Hers

Hims & Hers Bets Big on Provocative Super Bowl Ad Strategy

31.01.2026 - 13:18:04 | boerse-global.de

Hims & Hers US4330001060

Hims & Hers Bets Big on Provocative Super Bowl Ad Strategy - Foto: über boerse-global.de

The telehealth company Hims & Hers is launching a new national television campaign on February 8, strategically timed just before the Super Bowl. The campaign, titled "Rich People Live Longer," directly tackles the charged issue of inequality within the U.S. healthcare system. This move represents a doubling down on the firm's strategy of using provocative advertising to capture attention, even as investors await the company's upcoming financial results.

At the heart of the new advertisement is research cited by the company indicating that individuals in the top 1% of the income scale live, on average, seven years longer than those in the bottom 50%, based on median household income. The spot features narration by Grammy-award-winning artist Common.

This campaign follows last year's "Sick of the System" initiative, which, while drawing some criticism for its references to weight-loss medications, reportedly generated significant consumer interest and engagement for Hims & Hers. The company appears to be deliberately navigating the tension between courting controversy and achieving measurable marketing impact.

The Super Bowl as a Proven Growth Lever

For many brands, the Super Bowl is an expensive showcase. For Hims & Hers, historical data suggests it serves as a powerful lever for driving user growth. The company's 2025 Super Bowl appearance yielded concrete metrics, as reported by Forbes:

  • Website traffic surged by 650% within hours of the ad's airing.
  • The spot ranked 5th in overall engagement among all Super Bowl advertisements, according to EDO Inc.
  • In Apple's App Store rankings, the Hers app climbed to #2 and the Hims app reached #4 in the "Health & Wellness" category.

The upcoming campaign is therefore not merely a reach play but a repeat investment in a marketing channel with a demonstrated performance record.

Should investors sell immediately? Or is it worth buying Hims & Hers?

Financial Performance and Upcoming Catalyst

Alongside its marketing offensive, investor focus is shifting to the next earnings report. According to Nasdaq, Hims & Hers is scheduled to release its Q4 2025 results on February 23, 2026.

The company's recent financial performance has shown robust growth. For Q3 2025, Hims & Hers reported revenue of $598.98 million, a year-over-year increase of 49.2% (MarketBeat data). This continues a pattern of strong growth throughout the year:
* Q2 2025: Revenue of $544.83 million
* Q1 2025: Revenue of $586.01 million

Despite this, the stock has faced recent pressure. Shares closed at $27.09 on Friday, marking a decline of 9.31% and trading well below their 52-week high.

The immediate test will come on February 8, when the new Super Bowl ad airs and its impact on user engagement can be measured. The subsequent earnings report on February 23 will then be crucial in determining whether the company's high-profile marketing efforts are fundamentally supported by sustained revenue growth.

Ad

Hims & Hers Stock: Buy or Sell?! New Hims & Hers Analysis from January 31 delivers the answer:

The latest Hims & Hers figures speak for themselves: Urgent action needed for Hims & Hers investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 31.

Hims & Hers: Buy or sell? Read more here...

So schätzen die Börsenprofis Hims Aktien ein!

<b>So schätzen die Börsenprofis  Hims Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
US4330001060 | HIMS | boerse | 68537862 |